For patients and caregivers

Lupus (SLE) clinical trials

Short answer: our physician practices run lupus research studies on a rolling basis, meaning studies open and close throughout the year. This page explains what these studies are like and who they may fit. Whether one is open for you right now depends on the specific study, and the first step is always a conversation, never a commitment.

What is lupus?

Lupus is a condition where the immune system can affect many parts of the body at once, including joints, skin, kidneys, and energy levels. It flares and quiets unpredictably, which is part of what makes it hard to live with and important to study.

Who might these studies be for?

People whose lupus stays active despite current treatment, people managing flares that keep interrupting life, and people interested in newer approaches being studied. Lupus studies often have detailed entry criteria, so the screening conversation matters more here than in most conditions. One honest boundary: not every person with this condition will qualify, and eligibility always depends on the specific study's criteria.

Is a study open right now?

Studies open and close on a rolling basis, so the honest answer changes month to month. Our network recently achieved one of only a handful of randomizations worldwide in a global lupus study, and lupus remains one of our most active research priorities. The fastest way to hear when something matches: join the registry once, and a coordinator contacts you when a fitting study opens, typically before public recruitment begins.

What does it cost, and is there compensation?

Study-related visits, exams, and investigational treatment come at no cost to you, and most studies compensate participants for time and travel. Specific compensation depends on the study and is explained clearly before you decide anything.

What happens after you enquire?

A coordinator contacts you, typically within one to two business days, for a plain-language conversation with no commitment attached. If a study fits, a screening visit follows, after an informed consent you can take home first. Participation is voluntary at every step, you can withdraw at any time for any reason, and your regular medical care never depends on your answer. The full walkthrough is in what happens at your first study visit and are clinical trials safe.

Interested, or just curious?

Both are fine. Join the registry, or email patients@stryderesearch.com with your questions; a real person answers.

Join the registry